X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-20 | EYPT | Dicicco Wendy F | Dir | P - Purchase | $7.79 | +2,567 | 9,967 | +35% | +$19,997 | ||||||
2024-08-21 | EYPT | Ando Goran | Dir | P - Purchase | $7.95 | +5,000 | 13,150 | +61% | +$39,750 | ||||||
2024-08-19 | EYPT | Zaderej Karen L. | Dir | P - Purchase | $7.98 | +12,500 | 16,500 | +313% | +$99,750 | ||||||
2024-08-16 | EYPT | Lurker Nancy | Dir | P - Purchase | $7.88 | +3,173 | 224,524 | +1% | +$25,003 | ||||||
| D | 2024-07-12 | EYPT | Guyer David R | Dir | S - Sale+OE | $10.06 | -11,625 | 1,850 | -86% | -$116,995 | |||||
| D | 2024-05-14 | EYPT | Guyer David R | Dir | S - Sale+OE | $12.65 | -11,625 | 5,550 | -68% | -$147,045 | |||||
2024-05-06 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850,000 | 8,325,000 | +11% | +$10,081,721 | ||||||
2024-04-18 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
| D | 2024-02-02 | EYPT | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $28.49 | -209 | 37,962 | -1% | -$5,954 | |||||
| D | 2024-01-26 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.66 | -49,325 | 36,505 | -57% | -$1,265,539 | |||||
| D | 2024-01-26 | EYPT | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $25.38 | -26,017 | 37,962 | -41% | -$660,370 | |||||
| D | 2024-01-25 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.00 | -600 | 36,505 | -2% | -$15,000 | |||||
| DM | 2024-01-24 | EYPT | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $25.01 | -11,900 | 37,962 | -24% | -$297,621 | |||||
| DM | 2024-01-23 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.01 | -16,386 | 36,505 | -31% | -$409,790 | |||||
| DM | 2024-01-23 | EYPT | Lurker Nancy | Exec Vice Chair | S - Sale+OE | $24.98 | -35,000 | 187,649 | -16% | -$874,200 | |||||
| DM | 2024-01-22 | EYPT | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $22.68 | -35,066 | 37,962 | -48% | -$795,191 | |||||
2024-01-11 | EYEP | Ocumension Therapeutics | Dir | S - Sale | $19.45 | -1,910,500 | 100,221 | -95% | -$37,159,225 | ||||||
2024-01-11 | EYPT | Liu Ye | Dir | S - Sale | $19.45 | -1,910,500 | 100,221 | -95% | -$37,159,225 | ||||||
| M | 2024-01-09 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $19.94 | +855,000 | 6,893,235 | +14% | +$17,051,100 | |||||
| D | 2024-01-08 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $21.13 | -22,913 | 36,505 | -39% | -$484,124 | |||||
| D | 2023-12-13 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $20.00 | -1,458 | 25,707 | -5% | -$29,160 | |||||
2023-12-08 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $17.00 | +588,235 | 6,038,235 | +11% | +$9,999,995 | ||||||
| AD | 2023-12-04 | EYPT | Pine Michael Craig | Chief Corp Dev., Strat. Office | S - Sale+OE | $21.97 | -46,000 | 4,343 | -91% | -$1,010,790 | |||||
| M | 2023-12-05 | EYEP | Ocumension Therapeutics | Dir | S - Sale | $19.51 | -1,000,000 | 2,010,721 | -33% | -$19,510,637 | |||||
| M | 2023-12-05 | EYPT | Liu Ye | Dir | S - Sale | $19.51 | -1,000,000 | 2,010,721 | -33% | -$19,510,637 | |||||
| D | 2023-12-04 | EYPT | Pine Michael Craig | Chief Corp Dev., Strat. Office | S - Sale+OE | $22.00 | -45,000 | 5,343 | -89% | -$990,000 | |||||
| D | 2023-12-04 | EYPT | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $22.00 | -30,625 | 25,707 | -54% | -$673,750 | |||||
2023-12-04 | EYPT | Lurker Nancy | Exec Vice Chair | S - Sale | $20.76 | -20,000 | 170,559 | -10% | -$415,200 | ||||||
2023-12-04 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $21.82 | +1,919,057 | 5,450,000 | +54% | +$41,874,151 | ||||||
| A | 2023-09-01 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 3, 10% | S - Sale | $9.90 | -20,000 | 3,490,921 | -1% | -$197,982 | |||||
2023-09-01 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 3, 10% | S - Sale | $9.90 | -20,000 | 3,490,921 | -1% | -$197,982 | ||||||
| M | 2023-08-30 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 6, 10% | S - Sale | $10.54 | -139,471 | 3,510,921 | -4% | -$1,470,208 | |||||
| M | 2023-08-28 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 4, 10% | S - Sale | $11.14 | -148,712 | 3,650,392 | -4% | -$1,656,878 | |||||
| AM | 2023-08-24 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 6, 10% | S - Sale | $11.11 | -223,936 | 3,799,104 | -6% | -$2,487,482 | |||||
| M | 2023-08-24 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 2, 10% | S - Sale | $13.25 | -223,936 | 3,799,104 | -6% | -$2,967,572 | |||||
| M | 2023-08-22 | EYPT | Ew Healthcare Partners, L.P. | See footnotes 1 and 2, 10% | S - Sale | $13.49 | -167,881 | 4,023,040 | -4% | -$2,264,748 | |||||
2023-05-30 | EYPT | Liu Ye | Dir | S - Sale | $6.00 | -1 | 3,010,721 | 0% | -$6 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |